Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations



Rating:

Share or cite this content

Citations should be made in the following way:
J. Reeb, P. E. Falcoz, N. Santelmo, Z. Mansour, A. C. Lejay, S. Renaud, A. Parissiadis, D. Hanau, R. Kessler, G. Massard (Strasbourg, France). Significance of anti-HLA immunization in lung transplantation. Eur Respir J 2011; 38: Suppl. 55, 220

Member's Comments

No comment yet.

Related content which might interest you: Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation Source: Eur Respir J, 50 (5) 1701248; 10.1183/13993003.01248-2017 Year: 2017 Intragraft donor-specific antibodies and lung transplantation Source: Eur Respir J, 54 (5) 1901937; 10.1183/13993003.01937-2019 Year: 2019 De novo anti-HLA immunization after lung transplantation: Immunological monitoring and clinical signification Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction Source: Eur Respir J, 54 (5) 1900847; 10.1183/13993003.00847-2019 Year: 2019 Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome Source: Eur Respir J, 52 (2) 1701898; 10.1183/13993003.01898-2017 Year: 2018 Pre-transplant soluble CD30 is a stronger predictor of BOS than anti-HLA antibodies occurring after lung transplantation Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Is gammaglobuline anti-CMV warranted in lung transplantation? Source: Eur Respir J 2005; 26: Suppl. 49, 636s Year: 2005 The impact of pre-transplant donor specific anti-HLA antibodies (DSAs) on lung transplant outcome: A single center experience Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019 Antibodies against P. aeruginosa exoproteases in BAL from lung transplant recipients Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Lung transplantation Source: Procedure Video 2011 Year: 2011 Humoral rejection: the state-of-the-art in lung transplantation Source: International Congress 2016 – New frontiers in lung transplantation Year: 2016 Lung transplantation after allogeneic bone-marrow transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 634s Year: 2005 Association between tacrolimus levels in the first fifteen days post lung transplant and rejection during the first year Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Paediatric lung transplantation Source: Eur Respir J 2004; 24 : 839-845 Year: 2004 Lung transplantation Source: Respipedia Article Year: 2019 A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome Source: Eur Respir J, 58 (5) 2004090; 10.1183/13993003.04090-2020 Year: 2021 Utility of C4d by immunohistochemistry for the diagnosis of antibody-mediated rejection in lung transplantation Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation Source: Eur Respir J 2016; 48: 1807-1810 Year: 2016